TrialHeart and vessels2024

Impact of pemafibrate on lipid profile and insulin resistance in hypertriglyceridemic patients with coronary artery disease and metabolic syndrome.

Akihiro Nakamura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.